Xue-Ying Qiao

Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making

Si-Ye Chen, Yong Yang, Shu‐Nan Qi et al. · Leukemia · 2020 · 131 citations · Full text

Medicine, Oncology, Cancer Immunology +13

First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG

Shu‐Nan Qi, Yong Yang, Yu-Qin Song et al. · Blood Advances · 2020 · 57 citations · Full text

Medicine, Oncology, Cancer Immunology +12

Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study

Yong Yang, Ying Wang, Xin Liu et al. · Leukemia · 2020 · 31 citations · Full text

Medicine, Oncology, Hematologic Oncology +12

Comparison of Efficacy of Regional and Extensive Clinical Target Volumes in Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma

Xue-Ying Qiao, Wei Wang, Zhi-Guo Zhou et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 25 citations

Medicine, Oncology, Radiation Oncology +16

Late course accelerated hyperfractionation radiotherapy concomitant with cisplatin in patients with esophageal carcinoma

Xian-Shu Gao, Xue-Ying Qiao, Xiang-ran Yang et al. · Oncology Reports · 2002 · 24 citations

Medicine, Oncology, Radiation Oncology +12